The Growing CBD Industry in Europe
December 5, 2021

CBD is seeing monumental demand in Europe. The growth of the CBD market in Europe is growing because of the adoption of CBD infused products in industries such as pharmaceuticals, personal care, cosmetics, nutraceuticals, along with medical applications. In particular, legalisation of medical cannabis, and decriminalization in some countries, has led to a significant decrease in black-market activity, as people are shifting to legally purchasing cannabis for medical as well as recreational use. The legal cannabis industry continues to expand around the world with major contribution to the market coming from continuous legislative victories in North America and Europe. In Europe alone, the market is on course to grow 400% over the next four years, according to the Brightfield Group report. Another report from New Frontier data supports that projected growth in a report that said 46% of Europeans view CBD favorably, and up to 77% of surveyed respondents also believe CBD should be accessible in some way.

Other News

Canapa Mundi Rome 2022

Canapa Mundi Rome 2022

Our most important takeaway from Canapa Mundi was that everyone seems to be on the same page as us that the way forward for the hemp sector is to move away from the gray legal framework that the industry has been based on to go towards a much clearer and well defined industry where everyone from farmer to Government agency is in complete understanding of what is and is not legal as it relates to CBD.

read more
Highest CBD EU certified seed. Now Available!

Highest CBD EU certified seed. Now Available!

Our years of hard work and dedication has been celebrated by the European department of agriculture. Two of our high CBD, low THC strains have been registered into the EU seed catalog and received their Blue Label.

read more
Is CBD the answer to the Covid-19 Pandemic?

Is CBD the answer to the Covid-19 Pandemic?

Richard Van Breemen Ph.D and his team of researchers recently published their findings in The Journal of Natural Products. The study found that a number of Hemp derived compounds such as CBGA and CBDA can bind themselves to the SARS-CoV-2 spike protein, which blocks a critical step in the infection process in humans. This is the same process pharmaceutical companies use in the development of Covid-19 vaccines.

read more